Measuring the survival of transfused red blood cells in patients with Sickle cell disease and b-Thalassemia: A Biotin Label approach

Measuring the survival of transfused red blood cells in patients with Sickle cell disease and b-Thalassemia: A Biotin Label approach - Mr. STABLE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50011

Enrollment

Registered

2019-03-18

Start date

2019-08-29

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

beta-thalassemia Sickle cell disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with sickle cell disease or beta-thalassemia on chronic transfusion scheme, >18 jaar

Exclusion criteria

Exclusion criteria: No informed consent No venous access

Design outcomes

Primary

Measure	Time frame
- Assessment of survival of transfused RBCs in patients with sickle cell disease and *-thalassemia	—

Secondary

Measure	Time frame
- Determination of effect of antigen matching on survival of transfused units - Inflammatory response on transfused RBCs	—

Countries

Netherlands

Outcome results